Published in Virol J on June 29, 2010
Fc receptor but not complement binding is important in antibody protection against HIV. Nature (2007) 7.96
Complement. Second of two parts. N Engl J Med (2001) 6.32
Coming to terms with complexity: a call to action for HIV prevention. Lancet (2008) 3.15
Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med (1995) 2.12
Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol (1997) 1.59
Acquisition of host cell-surface-derived molecules by HIV-1. AIDS (1996) 1.46
Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J Immunol (1996) 1.39
Protection from HIV/AIDS: the importance of innate immunity. Clin Immunol (2003) 1.24
Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J Exp Med (1996) 1.23
Complement-HIV interactions during all steps of viral pathogenesis. Vaccine (2007) 1.19
Role of complement in HIV infection. Annu Rev Immunol (1997) 1.18
A revival of bispecific antibodies. Trends Biotechnol (2004) 1.11
Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18). J Immunol (2004) 1.10
Complement-opsonized HIV: the free rider on its way to infection. Mol Immunol (2005) 1.09
Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis. Virology (1998) 1.03
Humoral immunity to HIV-1: neutralisation and antibody effector functions. Trends Microbiol (2008) 1.02
Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. J Clin Invest (1995) 0.98
HIV and complement: hijacking an immune defense. Biomed Pharmacother (2006) 0.96
Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology (1995) 0.95
C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells. Eur J Immunol (2005) 0.92
HIV and human complement: inefficient virolysis and effective adherence. Immunol Lett (2004) 0.89
A "complement-ary" AIDS vaccine. Nat Med (1996) 0.84
A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement. Virol J (2009) 0.79
Enhancement of complement-mediated lysis by a peptide derived from SCR 13 of complement factor H. Immunobiology (2001) 0.79
Genome sequencing in microfabricated high-density picolitre reactors. Nature (2005) 150.21
Ancient human genome sequence of an extinct Palaeo-Eskimo. Nature (2010) 7.51
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol (2006) 6.30
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73
Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science (2010) 4.96
An Aboriginal Australian genome reveals separate human dispersals into Asia. Science (2011) 4.84
Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 4.71
An index of substitution saturation and its application. Mol Phylogenet Evol (2003) 4.71
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet (2011) 3.66
FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell (2011) 3.58
Adhesive phase separation at the dentin interface under wet bonding conditions. J Biomed Mater Res (2002) 3.08
N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion. Antimicrob Agents Chemother (2004) 2.76
Manipulating surface states in topological insulator nanoribbons. Nat Nanotechnol (2011) 2.70
Large electrocaloric effect in ferroelectric polymers near room temperature. Science (2008) 2.66
Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation (2010) 2.57
Autophagic proteins regulate cigarette smoke-induced apoptosis: protective role of heme oxygenase-1. Autophagy (2008) 2.38
Relationship of solvent to the photopolymerization process, properties, and structure in model dentin adhesives. J Biomed Mater Res A (2007) 2.26
The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol (2009) 2.23
High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol (2006) 2.19
Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet (2012) 2.17
Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol (2007) 2.16
Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis (2009) 2.13
Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin Cancer Res (2005) 2.13
The Arabidopsis NPR1 protein is a receptor for the plant defense hormone salicylic acid. Cell Rep (2012) 2.13
MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One (2011) 2.10
Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol (2006) 2.08
Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood (2010) 2.04
DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal (2010) 2.04
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology (2005) 2.03
Microfluidic device for multimodal characterization of pancreatic islets. Lab Chip (2008) 1.99
Adhesive/Dentin interface: the weak link in the composite restoration. Ann Biomed Eng (2010) 1.96
P450 enzymes: their structure, reactivity, and selectivity-modeled by QM/MM calculations. Chem Rev (2010) 1.95
Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res (2003) 1.86
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther (2008) 1.86
IFITM proteins restrict viral membrane hemifusion. PLoS Pathog (2013) 1.86
Pyrosequencing reveals highly diverse and species-specific microbial communities in sponges from the Red Sea. ISME J (2010) 1.84
Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One (2010) 1.82
Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate. PLoS Pathog (2012) 1.79
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci U S A (2007) 1.76
A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology (2005) 1.75
Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J Clin Invest (2010) 1.74
Characterization of photopolymerization of dentin adhesives as a function of light source and irradiance. J Biomed Mater Res B Appl Biomater (2007) 1.73
Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol (2011) 1.73
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol (2005) 1.70
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest (2005) 1.70
A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. J Immunol (2008) 1.70
Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice. Arterioscler Thromb Vasc Biol (2011) 1.69
N'-[4-(Dimethyl-amino)benzyl-idene]benzohydrazide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.68
Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem Biol (2010) 1.68
Halogen bonding--a novel interaction for rational drug design? J Med Chem (2009) 1.68
Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol (2008) 1.67
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun (2004) 1.67
Antiemetic placebo: reduce adverse drug interactions between chemotherapeutic agents and antiemetic drugs in cancer patients. Med Hypotheses (2007) 1.62
Comprehensive molecular etiology analysis of nonsyndromic hearing impairment from typical areas in China. J Transl Med (2009) 1.62
Alignment of molecular networks by integer quadratic programming. Bioinformatics (2007) 1.61
NOA: a novel Network Ontology Analysis method. Nucleic Acids Res (2011) 1.60
Nanophase separation of polymers exposed to simulated bonding conditions. J Biomed Mater Res B Appl Biomater (2009) 1.56
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions. Proc Natl Acad Sci U S A (2003) 1.54
Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension. J Heart Lung Transplant (2010) 1.54
A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.54
Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem (2006) 1.53
Complement function in mAb-mediated cancer immunotherapy. Trends Immunol (2004) 1.52
Prediction of protein-RNA binding sites by a random forest method with combined features. Bioinformatics (2010) 1.52
Altered microRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol (2009) 1.51
Research and development of universal influenza vaccines. Microbes Infect (2010) 1.49
Composite tissue allograft transplantation of cephalocervical skin flap and two ears. Plast Reconstr Surg (2005) 1.47
High severity and fatality of human infections with avian influenza A(H7N9) infection in China. Clin Infect Dis (2013) 1.47
Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J Clin Invest (2003) 1.46
The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients. Leuk Res (2009) 1.46
Insulin secretory deficiency and glucose intolerance in Rab3A null mice. J Biol Chem (2003) 1.46
Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. J Biol Chem (2009) 1.45
Vertical stratification of microbial communities in the Red Sea revealed by 16S rDNA pyrosequencing. ISME J (2010) 1.45
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. Blood (2012) 1.45
The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry (2002) 1.45
Structural basis for processivity and single-strand specificity of RNase II. Mol Cell (2006) 1.44
Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol (2011) 1.44
On the origin of Lake Malawi cichlid species: a population genetic analysis of divergence. Proc Natl Acad Sci U S A (2005) 1.43
Scrub typhus in previously unrecognized areas of endemicity in China. J Clin Microbiol (2010) 1.41
Members of the PHO1 gene family show limited functional redundancy in phosphate transfer to the shoot, and are regulated by phosphate deficiency via distinct pathways. Plant J (2007) 1.39
Clinical significance of IL-18 gene over-expression in AML. Leuk Res (2002) 1.39
Interfacial chemistry of moisture-aged class II composite restorations. J Biomed Mater Res B Appl Biomater (2006) 1.38
Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett (2009) 1.38
Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method. Proc Natl Acad Sci U S A (2008) 1.38
Synthesis and herbicidal activity of novel alpha,alpha,alpha-trifluoro-m-tolyl pyridazinone derivatives. Pest Manag Sci (2006) 1.37
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol (2011) 1.37
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine (2006) 1.36
Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Cancer Res (2009) 1.34